230 related articles for article (PubMed ID: 8396087)
21. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
Guay DR; Craft JC
J Intern Med; 1992 Mar; 231(3):295-301. PubMed ID: 1532615
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
Poirier R
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
[TBL] [Abstract][Full Text] [Related]
23. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
Roord JJ; Wolf BH; Gossens MM; Kimpen JL
Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837
[TBL] [Abstract][Full Text] [Related]
24. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Busman TA; Norris S; Notario GF
Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
[TBL] [Abstract][Full Text] [Related]
25. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
26. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Kinasewitz G; Wood RG
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):872-7. PubMed ID: 1662636
[TBL] [Abstract][Full Text] [Related]
27. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J
Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
[TBL] [Abstract][Full Text] [Related]
29. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis.
Aldons PM
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():101-8. PubMed ID: 1827095
[TBL] [Abstract][Full Text] [Related]
30. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
32. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
[TBL] [Abstract][Full Text] [Related]
33. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
Felstead SJ; Daniel R
J Int Med Res; 1991; 19(5):363-72. PubMed ID: 1660823
[TBL] [Abstract][Full Text] [Related]
34. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Wilson R; Schentag JJ; Ball P; Mandell L;
Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
[TBL] [Abstract][Full Text] [Related]
35. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Chodosh S; DeAbate CA; Haverstock D; Aneiro L; Church D
Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
[TBL] [Abstract][Full Text] [Related]
36. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
Principi N; Esposito S
Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
[TBL] [Abstract][Full Text] [Related]
37. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis.
Fraschini F
J Int Med Res; 1990; 18(2):171-6. PubMed ID: 2140331
[TBL] [Abstract][Full Text] [Related]
39. Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections.
Allin D; James I; Zachariah J; Carr W; Cullen S; Middleton A; Newson P; Lytle T; Coles S
Clin Ther; 2001 Dec; 23(12):1958-68. PubMed ID: 11813931
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
Anzueto A; Fisher CL; Busman T; Olson CA
Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
